Involvement of cytochrome P450 in cisplatin treatment: implications for toxicity (Q39371239)

11 September 2017

1 reference

title

Involvement of cytochrome P450 in cisplatin treatment: implications for toxicity (English)

1 reference

11 September 2017

1 reference

Júlia Coelho França Quintanilha

1

1 reference

11 September 2017

Vanessa Marcilio de Sousa

2

1 reference

11 September 2017

Marília Berlofa Visacri

3

1 reference

11 September 2017

Laís Sampaio Amaral

4

1 reference

11 September 2017

Roseane Maria Maia Santos

5

1 reference

11 September 2017

Tomás Zambrano

6

1 reference

11 September 2017

Luis Antonio Salazar

7

1 reference

11 September 2017

Patricia Moriel

8

1 reference

11 September 2017

publication date

13 June 2017

1 reference

Cancer Chemotherapy and Pharmacology

11 September 2017

published in

1 reference

11 September 2017

volume

80

1 reference

11 September 2017

issue

2

1 reference

11 September 2017

page(s)

223-233

1 reference

Carboplatin versus cisplatin in solid tumors: An analysis of the literature

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Biochemical modulation of Cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Platinum drug distribution in cancer cells and tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Biochemical mechanisms of cisplatin cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Platinum-DNA interactions and subsequent cellular processes controlling sensitivity to anticancer platinum complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

The role of metallothionein, glutathione, glutathione S-transferases and DNA repair in resistance to platinum drugs in a series of L1210 cell lines made resistant to anticancer platinum agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Molecular mechanisms of resistance and toxicity associated with platinating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Copper transporter 2 regulates the cellular accumulation and cytotoxicity of Cisplatin and Carboplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Up-regulation of transporters of the MRP family by drugs and toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Overexpression of cMOAT (MRP2/ABCC2) is associated with decreased formation of platinum-DNA adducts and decreased G2-arrest in melanoma cells resistant to cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Platinum Compounds: a New Class of Potent Antitumour Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Protective effect of caffeic acid phenethyl ester (CAPE) administration on cisplatin-induced oxidative damage to liver in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Hesperidin attenuates cisplatin-induced acute renal injury by decreasing oxidative stress, inflammation and DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Cisplatin ototoxicity: involvement of iron and enhanced formation of superoxide anion radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Implications of apurinic/apyrimidinic endonuclease in reactive oxygen signaling response after cisplatin treatment of dorsal root ganglion neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Hydroxyl radical scavenger ameliorates cisplatin-induced nephrotoxicity by preventing oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

D-methionine provides excellent protection from cisplatin ototoxicity in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Cisplatin induces mitochondrial oxidative stress with resultant energetic metabolism impairment, membrane rigidification and apoptosis in rat liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Cytochrome p450 gene expression levels in peripheral blood mononuclear cells in comparison with the liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Cytochrome P450IIE1 is elevated in lymphocytes from poorly controlled insulin-dependent diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Expression and function of cytochrome p450 in brain drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Clinically important pharmacokinetic drug-drug interactions: role of cytochrome P450 enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Mechanisms of hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Toxicological Implications of Mitochondrial Localization of CYP2E1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Role of cytochrome P-450 2E1 in ethanol-, carbon tetrachloride- and iron-dependent microsomal lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Stable expression of human cytochrome P4502E1 in HepG2 cells: Characterization of catalytic activities and production of reactive oxygen intermediates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Induction of cytochrome P450 2E1 increases hepatotoxicity caused by Fas agonistic Jo2 antibody in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Lipopolysaccharide-induced liver injury in rats treated with the CYP2E1 inducer pyrazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

The role of renal proximal tubule P450 enzymes in chloroform-induced nephrotoxicity: utility of renal specific P450 reductase knockout mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Cytochrome P450-Mediated Metabolism and Nephrotoxicity ofN-(3,5-Dichlorophenyl)succinimide in Fischer 344 Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Mechanism of chloroform nephrotoxicity. III. Renal and hepatic microsomal metabolism of chloroform in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Molecular basis for several drug-induced nephropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Modulation of cytochrome P450 activity: implications for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Cisplatin-mediated cytotoxicity through inducing CYP4A 11 expression in human renal tubular epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Down-regulation of hepatic cytochrome P450 enzymes associated with cisplatin-induced acute renal failure in male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Cisplatin-induced hepatotoxicity is enhanced by elevated expression of cytochrome P450 2E1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Oxidative stress, toxicology, and pharmacology of CYP2E1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Tobacco smoke-dependent changes in cytochrome P450 1A1, 1A2, and 2E1 protein expressions in fetuses, newborns, pregnant rats, and human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Genetic Polymorphisms in the 5′-Flanking Region Change Transcriptional Regulation of the Human Cytochrome P450IIE1 Gene1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Different regulation and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5'-flanking region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Transcriptional activity of the tandem repeat polymorphism in the 5'-flanking region of the human CYP2E1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Association between Restriction Fragment Length Polymorphism of the Human Cytochrome P450IIE1 Gene and Susceptibility to Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Metabolism of Chloroform by Cytochrome P450 2E1 Is Required for Induction of Toxicity in the Liver, Kidney, and Nose of Male Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

Clinical pharmacokinetics and administration of established platinum drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-017-3358-X

10.1007/S00280-017-3358-X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference